A physiologically-based pharmacokinetic(PB-PK) model for ethylene dibromide: relevance of extrahepatic metabolism
- 20 July 2000
- journal article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 38 (8) , 707-716
- https://doi.org/10.1016/s0278-6915(00)00059-4
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroformToxicology, 1996
- Use of physiologically based pharmacokinetic modeling to investigate individual versus population riskToxicology, 1996
- P450 2E1 expression in liver, kidney, and lung of rats treated with single or combined inducersAlcohol, 1996
- The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substancesToxicology Letters, 1995
- Applying Simulation Modeling to Problems in Toxicology and Risk Assessment: A Short PerspectiveToxicology and Applied Pharmacology, 1995
- Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokineticsJournal of Toxicology and Environmental Health, 1995
- Human glutathione S-transferasesInternational Journal of Biochemistry, 1994
- Physiological Parameters in Laboratory Animals and HumansPharmaceutical Research, 1993
- An improved method for the separation and quantification of glutathione S-transferase subunits in rat tissue using high-performance liquid chromatographyJournal of Chromatography A, 1989
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987